These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28314855)

  • 1. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
    Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
    J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
    Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
    J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines.
    Kong L; Ma R; Yang X; Zhu Z; Guo H; He B; Wang B; Hao D
    Int Immunopharmacol; 2017 Oct; 51():31-39. PubMed ID: 28779592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.
    Gu R; Santos LL; Ngo D; Fan H; Singh PP; Fingerle-Rowson G; Bucala R; Xu J; Quinn JM; Morand EF
    Cytokine; 2015 Apr; 72(2):135-45. PubMed ID: 25647268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells.
    Blüml S; Friedrich M; Lohmeyer T; Sahin E; Saferding V; Brunner J; Puchner A; Mandl P; Niederreiter B; Smolen JS; Schabbauer G; Redlich K
    Ann Rheum Dis; 2015 Jan; 74(1):227-33. PubMed ID: 24078675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas/S1P
    Hutami IR; Izawa T; Mino-Oka A; Shinohara T; Mori H; Iwasa A; Tanaka E
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1274-1281. PubMed ID: 28687489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.
    Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH
    J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle-induced SIRT1 downregulation promotes osteoclastogenesis and osteolysis through ER stress regulation.
    Zhang L; Bao D; Li P; Lu Z; Pang L; Chen Z; Guo H; Gao Z; Jin Q
    Biomed Pharmacother; 2018 Aug; 104():300-306. PubMed ID: 29775898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
    Kassem A; Lindholm C; Lerner UH
    PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
    Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
    J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
    Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
    J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
    Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
    Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
    Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
    Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.